Cargando…
Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility
Covid-19 (SARS CoV-2) has become a deadly, world-wide pandemic. Although most who are infected survive, complications from the virus can be pronounced and long-lasting. To date, of all the respiratory viruses including influenza and coronaviruses, only influenza has had a drug (i.e., Tamiflu) specif...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659899/ https://www.ncbi.nlm.nih.gov/pubmed/33184504 http://dx.doi.org/10.1038/s41434-020-00210-0 |